 <html>
    <head>
        <link rel="icon" href="favicon.png">
        <title>Journal2Wiki</title>
        <link rel="stylesheet" type="text/css" href="layout.css" />
    </head>

    <div class="header"><h2>Index of Articles</h2></div>

    <div class="sidenav">
        <a href="about.html">About</a>
        <a href="index.html">Index</a>
    </div>
    <div class="main">
        <ul>
         <hr width="100%", align = "left", size="2"><li><a href="article174.html">3SITES - Catheter-Related Infections and Thrombosis in ICU Patients</a></li><h2 style="margin-bottom:0;">A</h2> <hr width="100%", align = "left", size="2"><li><a href="article106.html">A-HeFT - Iso-Dinitrate Plus Hydralazine in Black Patients with Heart Failure</a></li><li><a href="article140.html">ACCOMPLISH - Benazepril-Amlodipine or Benazepril-Hydrochlorothiazide in High-Risk Patients with Hypertension</a></li><li><a href="article64.html">ACCORD Lipid - Fenofibrate and Simvastatin Not Beneficial in Reducing Cardiovascular Events in Patients with Type 2 Diabetes</a></li><li><a href="article61.html">ACT I - Carotid-Artery Stenting versus Endarterectomy in Asymptomatic Patients</a></li><li><a href="article31.html">ACTIVE A - Clopidogrel with Aspirin in High-Risk Patients with Atrial Fibrillation (ACTIVE A)</a></li><li><a href="article257.html">ACTT-1 - Remdesivir for the Treatment of Covid-9 — Final Report</a></li><li><a href="article166.html">ACURASYS - Cisatracurium in Early Acute Respiratory Distress Syndrome</a></li><li><a href="article186.html">ADRENAL - Hydrocortisone for Patients with Septic Shock on Mechanical Ventilation</a></li><li><a href="article107.html">ADVOR - Acetazolamide in Patients with Acute Decompensated Heart Failure with Volume Overload</a></li><li><a href="article108.html">AF-CHF - Atrial Fibrillation and Congestive Heart Failure Treatment Strategies</a></li><li><a href="article32.html">AFFIRM - Management Strategies for Atrial Fibrillation</a></li><li><a href="article179.html">AID-ICU - Haloperidol for Delirium in Intensive Care Unit Patients</a></li><li><a href="article65.html">AIDA - Bioresorbable Vascular Scaffolds versus Metallic Stents in Routine PCI</a></li><li><a href="article162.html">AKIKI - Timing of Renal Replacement Therapy in Acute Kidney Injury</a></li><li><a href="article187.html">ALBIOS - Albumin Replacement in Patients with Severe Sepsis or Septic Shock</a></li><li><a href="article225.html">AMPLIFY - Apixaban versus Conventional Therapy in Venous Thromboembolism</a></li><li><a href="article226.html">AMPLIFY-EXT - Extended Anticoagulation with Apixaban for Venous Thromboembolism</a></li><li><a href="article242.html">ANNEXA - Reversal of Anticoagulation</a></li><li><a href="article138.html">ANNEXA-4 - Andexanet Alfa for Reversing Anticoagulation from Factor Xa Inhibitors</a></li><li><a href="article260.html">ANRS IPERGAY - Antiretroviral Preexposure Prophylaxis for HIV Prevention in Men Who Have Sex with Men</a></li><li><a href="article319.html">ANTLER - Effect of Antidepressant Discontinuation vs. Maintenance on Relapse in Primary Care Patients</a></li><li><a href="article227.html">APEX - BRIXABAN for Acute Medical Illness</a></li><li><a href="article188.html">APROCCHSS - Corticosteroids in Septic Shock: The APROCCHSS Trial</a></li><li><a href="article167.html">ARDSNet - Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome</a></li><li><a href="article189.html">ARISE - Early Goal-Directed Therapy in the Treatment of Septic Shock</a></li><li><a href="article33.html">ARISTOTLE - Apixaban versus Warfarin in Patients with Atrial Fibrillation</a></li><li><a href="article66.html">ART - Outcomes after Bilateral vs. Single Internal Thoracic Artery Grafting in Coronary-Artery Bypass Surgery</a></li><li><a href="article102.html">ASCEND (Aspirin) - Aspirin for Primary Prevention in Diabetes Mellitus</a></li><li><a href="article329.html">ASCEND (IPF) - Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis</a></li><li><a href="article256.html">ASPIRE - Aspirin for the Prevention of Recurrent Venous Thromboembolism</a></li><li><a href="article30.html">ASPREE - Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer in the Elderly</a></li><li><a href="article279.html">ASTRAL - Revascularization versus Medical Therapy for Renal-Artery Stenosis</a></li><li><a href="article200.html">ATHOS-3 - Angiotensin II for the Treatment of Vasodilatory Shock</a></li><li><a href="article163.html">ATN - Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury</a></li><li><a href="article109.html">ATTR-ACT - Tafamidis in Transthyretin Amyloid Cardiomyopathy</a></li><li><a href="article228.html">ATTRACT - Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis</a></li><li><a href="article34.html">AUGUSTUS - Antithrombotic Therapy in Patients with Atrial Fibrillation following Acute Coronary Syndrome or PCI</a></li><li><a href="article54.html">AURORA - Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis</a></li><li><a href="article35.html">AVERROES - Apixaban versus Aspirin in Patients with Atrial Fibrillation</a></li><li><a href="article229.html">AVERT - Apixaban for Thromboprophylaxis in Cancer Patients</a></li><li><a href="article261.html">AZT Trial - Azidothymidine (AZT) in Patients with AIDS or Advanced AIDS-Related Complex</a></li><li><a href="article208.html">Albumin for SBP - Albumin Infusion in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis</a></li><h2 style="margin-bottom:0;">B</h2> <hr width="100%", align = "left", size="2"><li><a href="article67.html">BARI 2D - Intensive Medical Therapy for Type 2 Diabetes and Stable Ischemic Heart Disease</a></li><li><a href="article68.html">BEST - Comparison of Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease (BEST Trial)</a></li><li><a href="article46.html">BLOCK-HF - Biventricular Pacing in Patients with Atrioventricular Block and Heart Failure</a></li><li><a href="article36.html">BRIDGE - Bridging Anticoagulation in Patients with Atrial Fibrillation</a></li><li><a href="article306.html">BRIM-3 - Vemurafenib versus Dacarbazine for Metastatic Melanoma with BRAF V600E Mutation</a></li><li><a href="article275.html">Benazepril in Severe CKD - Benazepril in Patients with Advanced Chronic Renal Insufficiency</a></li><li><a href="article141.html">Blood Pressure Reduction in Black Barbershops - Barbershop Interventions for Blood Pressure Reduction in Black Men</a></li><h2 style="margin-bottom:0;">C</h2> <hr width="100%", align = "left", size="2"><li><a href="article69.html">CANTOS - Canakinumab Antiinflammatory Thrombosis Outcome Study (CANTOS)</a></li><li><a href="article103.html">CANVAS - Canagliflozin in Patients with Type 2 Diabetes and Cardiovascular Disease</a></li><li><a href="article270.html">CAP-START - Empirical Antibiotic Treatment Strategies for Community-Acquired Pneumonia</a></li><li><a href="article183.html">CAPE COD - Hydrocortisone in Severe Community-Acquired Pneumonia</a></li><li><a href="article230.html">CARAVAGGIO - Apixaban for the Treatment of Venous Thromboembolism in Patients with Cancer</a></li><li><a href="article52.html">CARP - Coronary-Artery Revascularization before Elective Major Vascular Surgery (CARP Trial)</a></li><li><a href="article110.html">CARRESS-HF - Comparison of Ultrafiltration and Pharmacologic Therapy in Acute Decompensated Heart Failure</a></li><li><a href="article231.html">CASSINI - Thromboprophylaxis with Rivaroxaban in High-Risk Ambulatory Patients with Cancer</a></li><li><a href="article37.html">CASTLE-AF - Catheter Ablation for Atrial Fibrillation with Heart Failure</a></li><li><a href="article320.html">CATIE - Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia</a></li><li><a href="article318.html">CATIE-AD - Atypical Antipsychotic Drugs in Alzheimers Disease</a></li><li><a href="article312.html">CATT - Bevacizumab and Ranibizumab for Neovascular Age-Related Macular Degeneration (AMD)</a></li><li><a href="article2.html">CHAMPION PHOENIX - Cangrelor During PCI</a></li><li><a href="article286.html">CHANCE - Clopidogrel with Aspirin in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (CHANCE)</a></li><li><a href="article3.html">CHARISMA - Clopidogrel plus Aspirin versus Aspirin Alone in High-Risk Patients</a></li><li><a href="article219.html">CHOICE - Contraceptive CHOICE Project and Its Impact on Teen Pregnancy</a></li><li><a href="article220.html">CHOIR - Hemoglobin Target in Chronic Kidney Disease</a></li><li><a href="article100.html">CIRT - Inflammation and risk of atherothrombosis: Methotrexate versus placebo</a></li><li><a href="article150.html">CLOSURE I - Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale</a></li><li><a href="article232.html">CLOT - Dalteparin versus Oral Anticoagulant Therapy for the Prevention of Recurrence in Patients with Cancer and Venous Thromboembolism</a></li><li><a href="article146.html">COAPT - Transcatheter Mitral-Valve Repair in Heart Failure Patients with Mitral Regurgitation</a></li><li><a href="article70.html">COGENT - Clopidogrel with or without Omeprazole in Coronary Artery Disease</a></li><li><a href="article4.html">COLCOT - Colchicine in Patients with Recent Myocardial Infarction</a></li><li><a href="article213.html">COLONPREV - Comparative Effectiveness of Colonoscopy vs Fecal Immunochemical Testing for Colorectal Cancer Screening</a></li><li><a href="article72.html">COMPASS - Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease</a></li><li><a href="article111.html">CONSENSUS - Enalapril in Severe Congestive Heart Failure</a></li><li><a href="article55.html">CORAL - Renal-Artery Stenting versus Medical Therapy for Atherosclerotic Renal-Artery Stenosis</a></li><li><a href="article112.html">CORONA - Rosuvastatin in Older Patients with Systolic Heart Failure</a></li><li><a href="article190.html">CORTICUS - Corticosteroid Therapy of Septic Shock (CORTICUS)</a></li><li><a href="article73.html">COURAGE - Percutaneous Coronary Intervention for Stable Coronary Artery Disease</a></li><li><a href="article246.html">CRB-401 - CAR T-Cell Therapy bb22 in Relapsed or Refractory Multiple Myeloma</a></li><li><a href="article62.html">CREST - Carotid Stenting vs. Endarterectomy Trial (CREST)</a></li><li><a href="article74.html">CULPRIT-SHOCK - Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock (CULPRIT-SHOCK)</a></li><li><a href="article5.html">CURE - Clopidogrel in Patients with Acute Coronary Syndromes</a></li><li><a href="article147.html">CYTO-PV - Hematocrit Targeting in Polycythemia Vera</a></li><li><a href="article300.html">CheckMate-003 - Programmed Death  Blockade in Cancer Treatment</a></li><li><a href="article71.html">Compare-Acute - FFR-Guided PCI in ST-Segment Elevation Myocardial Infarction</a></li><li><a href="article317.html">Cytisine for Smoking Cessation - Cytisine versus Nicotine-Replacement Therapy for Smoking Cessation</a></li><h2 style="margin-bottom:0;">D</h2> <hr width="100%", align = "left", size="2"><li><a href="article159.html">DANISH - ICD in Patients with Nonischemic Systolic Heart Failure and the Risk of Sudden Cardiac Death</a></li><li><a href="article63.html">DAPA-CKD - Dapagliflozin in Patients with Chronic Kidney Disease</a></li><li><a href="article113.html">DAPA-HF - Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction</a></li><li><a href="article75.html">DAPT - Dual Antiplatelet Therapy with Clopidogrel and Aspirin in Coronary Stenting</a></li><li><a href="article142.html">DASH - Dietary Approaches to Stop Hypertension (DASH) Study</a></li><li><a href="article287.html">DAWN - Thrombectomy 6 to 24 Hours after Stroke</a></li><li><a href="article114.html">DEFINITE - Mortality and Morbidity with an Implantable Cardioverter–Defibrillator in Patients with Nonischemic Dilated Cardiomyopathy</a></li><li><a href="article115.html">DELIVER - Dapagliflozin in Heart Failure with Preserved Ejection Fraction (DELIVER)</a></li><li><a href="article148.html">DETO2X-AMI - Routine Oxygen Therapy in Suspected Acute Myocardial Infarction</a></li><li><a href="article116.html">DIG - Mortality and Hospitalization in Heart Failure Patients on Digoxin</a></li><li><a href="article117.html">DINAMIT - Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo</a></li><li><a href="article118.html">DONATE-HCV - Transplantation Outcomes in Organ Recipients from Donors with HCV Viremia</a></li><li><a href="article119.html">DOSE - Diuretic Strategies in Patients with Acute Decompensated Heart Failure</a></li><li><a href="article185.html">Daily ICU Sedation Holidays - Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical Ventilation</a></li><li><a href="article210.html">Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile - Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection</a></li><h2 style="margin-bottom:0;">E</h2> <hr width="100%", align = "left", size="2"><li><a href="article38.html">EARLY-AF - Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation</a></li><li><a href="article105.html">EASE - Early Surgery versus Conventional Treatment for Infective Endocarditis</a></li><li><a href="article39.html">EAST-AFNET 4 - Early Rhythm-Control Therapy in Patients with Atrial Fibrillation</a></li><li><a href="article288.html">ECASS III - Alteplase for Stroke 3 to 4.5 Hours after Onset</a></li><li><a href="article233.html">EINSTEIN CHOICE - Rivaroxaban for the Prevention of Venous Thromboembolism</a></li><li><a href="article249.html">EINSTEIN-PE - Rivaroxaban versus Standard Therapy for Pulmonary Embolism Treatment</a></li><li><a href="article280.html">ELITE-Symphony - Daclizumab, Mycophenolate Mofetil, and Corticosteroids Combined with Low-Dose Tacrolimus, Cyclosporine, or Sirolimus in Renal Transplantation</a></li><li><a href="article40.html">EMBRACE - Atrial fibrillation detection after stroke</a></li><li><a href="article298.html">EMILIA - Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer</a></li><li><a href="article104.html">EMPA-REG OUTCOME - Empagliflozin in High Cardiovascular Risk Patients with Type 2 Diabetes</a></li><li><a href="article120.html">EMPHASIS-HF - Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms</a></li><li><a href="article41.html">ENGAGE AF-TIMI 48 - Edoxaban versus Warfarin in Patients with Atrial Fibrillation</a></li><li><a href="article234.html">EPCAT II - Extended Thromboprophylaxis with Aspirin versus Rivaroxaban after Total Hip or Knee Arthroplasty</a></li><li><a href="article6.html">EPHESUS - Eplerenone in Patients with Left Ventricular Dysfunction after Myocardial Infarction</a></li><li><a href="article309.html">ERSPC - European Randomized Study of Screening for Prostate Cancer (ERSPC)</a></li><li><a href="article7.html">ESSENCE - Enoxaparin versus Unfractionated Heparin in Unstable Coronary Artery Disease</a></li><li><a href="article154.html">EUCLID (Ticagrelor) - Ticagrelor versus Clopidogrel in Patients with Symptomatic Peripheral Artery Disease</a></li><li><a href="article274.html">EVOLVE - Cinacalcet in Patients Undergoing Hemodialysis</a></li><li><a href="article76.html">EXCEL - Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease</a></li><li><a href="article301.html">Early Palliative Care - Palliative Care in Patients with Metastatic Non–Small-Cell Lung Cancer</a></li><li><a href="article209.html">Early TIPS - Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding</a></li><li><a href="article267.html">European Dexamethasone Study - Dexamethasone in Adults with Bacterial Meningitis</a></li><h2 style="margin-bottom:0;">F</h2> <hr width="100%", align = "left", size="2"><li><a href="article168.html">FACTT - Fluid Management Strategies in Acute Lung Injury</a></li><li><a href="article121.html">FAIR-HF - Iron Supplementation in Heart Failure with Reduced Ejection Fraction and Iron Deficiency</a></li><li><a href="article77.html">FAME - Fractional Flow Reserve-Guided PCI versus Angiography for Multivessel Evaluation (FAME) Study</a></li><li><a href="article78.html">FAME 2 - Fractional Flow Reserve-Guided PCI for Stable Coronary Artery Disease</a></li><li><a href="article201.html">FEAST - Fluid Boluses in African Children with Severe Infection</a></li><li><a href="article42.html">FIRE AND ICE - Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation</a></li><li><a href="article323.html">FLAME (COPD) - Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD</a></li><li><a href="article221.html">FOCUS - Liberal or Restrictive Transfusion after Hip Fracture Surgery</a></li><li><a href="article79.html">FOURIER - Evolocumab in Patients with Cardiovascular Disease</a></li><li><a href="article80.html">FREEDOM - CABG vs. PCI in Diabetes with Multivessel Disease</a></li><li><a href="article211.html">Fidaxomicin in C. difficile Diarrhea - Fidaxomicin versus Vancomycin for Clostridium difficile Infection</a></li><h2 style="margin-bottom:0;">G</h2> <hr width="100%", align = "left", size="2"><li><a href="article182.html">GI bleeding in ICU patients - Risk Factors for Gastrointestinal Bleeding in Critically Ill Patients</a></li><li><a href="article8.html">GUSTO - Mortality and Morbidity with Thrombolytic Regimens in Myocardial Infarction: The GUSTO Trial</a></li><h2 style="margin-bottom:0;">H</h2> <hr width="100%", align = "left", size="2"><li><a href="article49.html">HACA - Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest</a></li><li><a href="article122.html">HEARTMATE II - Comparison of Continuous-Flow and Pulsatile-Flow Left Ventricular Assist Devices in Advanced Heart Failure</a></li><li><a href="article181.html">HEAT - Acetaminophen for Fever in Critically Ill Patients with Suspected Infection</a></li><li><a href="article276.html">HEMO - Dialysis Dose and the Effect of Membrane Flux in Maintenance Hemodialysis</a></li><li><a href="article299.html">HERA - Trastuzumab for HER2-Positive Early Breast Cancer</a></li><li><a href="article252.html">HOPE (Sickle Cell Disease) - Voxelotor in Patients with Sickle Cell Disease (HOPE Trial)</a></li><li><a href="article81.html">HOPE - Ramipril in High-Risk Patients</a></li><li><a href="article56.html">HOPE-3 - Combined Effects of Lowering LDL Cholesterol and Blood Pressure on Cardiovascular Disease</a></li><li><a href="article205.html">HORIZON-PFT - Zoledronic Acid and Fracture Risk Reduction</a></li><li><a href="article82.html">HPS2-THRIVE - Extended-Release Niacin or Laropiprant and Vascular Outcomes</a></li><li><a href="article262.html">HPTN 052 - Antiretroviral Therapy for the Prevention of HIV- Transmission</a></li><li><a href="article191.html">HYPRESS - Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Respiratory Distress Syndrome</a></li><li><a href="article143.html">HYVET - Hypertension Treatment in the Very Elderly</a></li><li><a href="article235.html">Hokusai-VTE - Edoxaban versus Dalteparin for Cancer-Associated Venous Thromboembolism</a></li><li><a href="article297.html">Hungarian Prenatal Vitamin Trial - Periconceptional Multivitamin and Folic Acid Supplementation Prevents Neural Tube Defects</a></li><h2 style="margin-bottom:0;">I</h2> <hr width="100%", align = "left", size="2"><li><a href="article9.html">IABP-SHOCK II - Intraaortic Balloon Counterpulsation in Acute Myocardial Infarction-Complicated Cardiogenic Shock</a></li><li><a href="article302.html">IALT - Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non-Small-Cell Lung Cancer</a></li><li><a href="article152.html">ICAP - Colchicine for Acute Pericarditis (ICAP)</a></li><li><a href="article277.html">IDEAL - Initiating Dialysis Early and Late (IDEAL) Study</a></li><li><a href="article164.html">IDEAL-ICU - Renal-Replacement Therapy in Septic Shock with Acute Kidney Injury</a></li><li><a href="article83.html">IFR-SWEDEHEART - Instantaneous Wave-Free Ratio versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome</a></li><li><a href="article10.html">IMPROVE-IT - Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes</a></li><li><a href="article328.html">INPULSIS Trials - Nintedanib for Idiopathic Pulmonary Fibrosis</a></li><li><a href="article263.html">INSIGHT START - Immediate Antiretroviral Therapy in Early HIV Infection</a></li><li><a href="article264.html">IPrEx - Preexposure Prophylaxis with FTC-TDF for HIV Prevention in Men</a></li><li><a href="article224.html">IRIS - Imatinib versus Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia</a></li><li><a href="article84.html">ISAR-REACT 5 - Ticagrelor versus Prasugrel in Acute Coronary Syndromes</a></li><li><a href="article85.html">ISCHEMIA - Invasive Strategy vs. Conservative Strategy in Stable Coronary Disease and Moderate or Severe Ischemia</a></li><li><a href="article245.html">Ibrutinib in Waldenstrom macroglobulinemia - Ibrutinib for Previously Treated Waldenströms Macroglobulinemia</a></li><li><a href="article223.html">Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia - Ibrutinib–Rituximab or Chemoimmunotherapy for CLL</a></li><h2 style="margin-bottom:0;">J</h2> <hr width="100%", align = "left", size="2"><li><a href="article86.html">JUPITER - Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein</a></li><h2 style="margin-bottom:0;">K</h2> <hr width="100%", align = "left", size="2"><li><a href="article303.html">KEYNOTE-024 - Pembrolizumab versus Chemotherapy for PD-L–Positive Non–Small-Cell Lung Cancer</a></li><h2 style="margin-bottom:0;">L</h2> <hr width="100%", align = "left", size="2"><li><a href="article57.html">LEADER - Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes</a></li><li><a href="article313.html">LESS - Epidural Glucocorticoids for Spinal Stenosis</a></li><li><a href="article247.html">LenDex in High-Risk Smoldering Myeloma - Clinical Question</a></li><li><a href="article244.html">Lo-Coco 2013 - ATRA plus Arsenic Trioxide for Acute Promyelocytic Leukemia</a></li><li><a href="article87.html">LoDoCo2 - Colchicine in Patients with Chronic Coronary Disease</a></li><li><a href="article58.html">Look AHEAD - Intensive Lifestyle Intervention in Type 2 Diabetes</a></li><h2 style="margin-bottom:0;">M</h2> <hr width="100%", align = "left", size="2"><li><a href="article123.html">MADIT-CRT - Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events</a></li><li><a href="article11.html">MADIT-II - Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction</a></li><li><a href="article236.html">MAGELLAN - Extended Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients</a></li><li><a href="article101.html">MARINER - Extended Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients</a></li><li><a href="article88.html">MASTER DAPT - Dual Antiplatelet Therapy Duration in High-Bleeding-Risk Patients After Stent Implantation</a></li><li><a href="article89.html">MATRIX Antithrombin - Bivalirudin versus Heparin in Acute Coronary Syndrome</a></li><li><a href="article314.html">METEOR - Arthroscopic Partial Meniscectomy versus Physical Therapy in Patients with Degenerative Meniscus Tears</a></li><li><a href="article175.html">MIND-USA - Antipsychotic Medications for Delirium in the Intensive Care Unit</a></li><li><a href="article269.html">MIST2 - Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection</a></li><li><a href="article212.html">MODIFY I and II - Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection</a></li><li><a href="article124.html">MOMENTUM 3 - Clinical Outcomes in Advanced Heart Failure Patients with Centrifugal-Flow vs. Axial-Flow Pump</a></li><li><a href="article47.html">MOST - Dual-Chamber versus Ventricular Pacing in Sinus-Node Dysfunction</a></li><li><a href="article307.html">MPACT - Nab-Paclitaxel plus Gemcitabine for Metastatic Pancreatic Cancer</a></li><li><a href="article289.html">MR CLEAN - Intraarterial Treatment for Acute Ischemic Stroke in the MR CLEAN Trial</a></li><li><a href="article290.html">MR RESCUE - Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection</a></li><li><a href="article253.html">MSH - Hydroxyurea for the Treatment of Sickle Cell Anemia</a></li><li><a href="article160.html">MUSTT - Electrophysiologically Guided Antiarrhythmic Therapy in Coronary Artery Disease Patients</a></li><li><a href="article315.html">Moseley Trial - A Randomized, Placebo-Controlled Trial of Arthroscopy for Osteoarthritis of the Knee</a></li><h2 style="margin-bottom:0;">N</h2> <hr width="100%", align = "left", size="2"><li><a href="article265.html">NA-ACCORD - Timing of Antiretroviral Therapy for HIV- Infection and Mortality</a></li><li><a href="article281.html">NASCET - Carotid Endarterectomy for Moderate Stenosis</a></li><li><a href="article291.html">NAVIGATE ESUS - Rivaroxaban versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source (NAVIGATE ESUS)</a></li><li><a href="article278.html">NCDS - Morbidity Effects of Hemodialysis Dose and Membrane Flux</a></li><li><a href="article125.html">NEAT-HFpEF - Nitrates in Patients with Heart Failure and Preserved Ejection Fraction (NEAT-HFpEF Trial)</a></li><li><a href="article324.html">NETT - Mortality and Morbidity in Patients with Severe Emphysema Treated with Lung-Volume-Reduction Surgery or Medical Therapy</a></li><li><a href="article304.html">NLST - National Lung Screening Trial (NLST)</a></li><li><a href="article90.html">NORSTENT - Long-term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Norway</a></li><li><a href="article316.html">NordICC - Clinical Effectiveness of Colonoscopy Screening in Reducing Colorectal Cancer Risk</a></li><li><a href="article321.html">Novel START - As-needed Budesonide–Formoterol in Mild Asthma</a></li><h2 style="margin-bottom:0;">O</h2> <hr width="100%", align = "left", size="2"><li><a href="article12.html">OASIS-5 - Fondaparinux versus Enoxaparin in Acute Coronary Syndromes (OASIS-5 Trial)</a></li><li><a href="article13.html">OAT - Percutaneous Coronary Intervention in Stable Patients with Occluded Infarct-Related Artery</a></li><li><a href="article139.html">ODYSSEY LONG TERM - Alirocumab for Hypercholesterolemia in Statin-Treated Patients</a></li><li><a href="article59.html">ONTARGET - Comparing Angiotensin Receptor Blockers and ACE Inhibitors for Patients with Vascular Disease or High-Risk Diabetes</a></li><li><a href="article60.html">ORIGIN n-3 Fatty Acids - N-3 Fatty Acids in High-Risk Patients with Dysglycemia</a></li><li><a href="article169.html">OSCILLATE - High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome</a></li><li><a href="article268.html">OVIVA - Oral versus Intravenous Antibiotics for Bone and Joint Infection (OVIVA)</a></li><li><a href="article215.html">Omeprazole in Peptic Ulcer Bleeding - High-Dose Proton-Pump Inhibitor for Peptic Ulcer Hemorrhage</a></li><h2 style="margin-bottom:0;">P</h2> <hr width="100%", align = "left", size="2"><li><a href="article218.html">PANTER - Minimally Invasive Step-Up Approach Versus Open Necrosectomy in Necrotizing Pancreatitis</a></li><li><a href="article126.html">PARADIGM-HF - LCZ696 versus Enalapril in Heart Failure</a></li><li><a href="article127.html">PARAGON-HF - Sacubitril-Valsartan in Heart Failure with Preserved Ejection Fraction</a></li><li><a href="article25.html">PARTNER 2 - Transcatheter versus Surgical Aortic-Valve Replacement in Intermediate-Risk Patients</a></li><li><a href="article26.html">PARTNER 3 - TAVR versus Surgery for Aortic Stenosis in Patients at Low Surgical Risk</a></li><li><a href="article27.html">PARTNER A - Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients</a></li><li><a href="article28.html">PARTNER B - Transcatheter Aortic-Valve Implantation for Inoperable Severe Aortic Stenosis</a></li><li><a href="article310.html">PCPT - Finasteride in the Prevention of Prostate Cancer</a></li><li><a href="article14.html">PEGASUS-TIMI 54 - Ticagrelor in Patients  to 3 Years after Myocardial Infarction</a></li><li><a href="article184.html">PEITHO - Tenecteplase in Normotensive Patients with Pulmonary Embolism</a></li><li><a href="article250.html">PESIT - Pulmonary Embolism Prevalence in Patients Hospitalized for Syncope</a></li><li><a href="article15.html">PIONEER AF-PCI - Rivaroxaban with or without Aspirin in Patients with Recent PCI and Atrial Fibrillation</a></li><li><a href="article128.html">PIONEER-HF - Sacubitril–Valsartan vs. Enalapril in Acute Decompensated Heart Failure</a></li><li><a href="article251.html">PIOPED II - Multidetector Computed Tomographic Angiography in Diagnosis of Pulmonary Embolism</a></li><li><a href="article16.html">PLATO - Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes</a></li><li><a href="article259.html">POET - Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis</a></li><li><a href="article292.html">POINT - Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA</a></li><li><a href="article53.html">POISE-2 ASA - Aspirin in Patients Undergoing Noncardiac Surgery</a></li><li><a href="article157.html">PRAETORIAN - Clinical Question</a></li><li><a href="article149.html">PRAMI - Preventive Angioplasty in Acute Myocardial Infarction (PRAMI)</a></li><li><a href="article91.html">PRECISION - Celecoxib vs. Ibuprofen or Naproxen in Patients with Increased Cardiovascular Risk</a></li><li><a href="article92.html">PREDIMED - Mediterranean Diet for Primary Prevention of Cardiovascular Disease</a></li><li><a href="article237.html">PREPIC - Efficacy of Vena Caval Filters in Preventing Pulmonary Embolism in Patients with Deep-Vein Thrombosis</a></li><li><a href="article271.html">PREVENT TB - Rifapentine and Isoniazid for 3 Months versus Isoniazid for 9 Months</a></li><li><a href="article308.html">PRODIGE 4 ACCORD 11 - FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer</a></li><li><a href="article238.html">PROLONG - Duration of Anticoagulation after Venous Thromboembolism</a></li><li><a href="article170.html">PROSEVA - Prone Positioning in Severe Acute Respiratory Distress Syndrome</a></li><li><a href="article17.html">PROVE IT-TIMI 22 - Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease</a></li><li><a href="article194.html">PROWESS - Drotrecogin Alfa (Activated) in Severe Sepsis</a></li><li><a href="article195.html">PROWESS-SHOCK - Drotrecogin Alfa (Activated) in Adults with Septic Shock</a></li><li><a href="article293.html">PRoFESS - Comparison of Aspirin plus Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke</a></li><li><a href="article206.html">Prednisolone in Severe Alcoholic Hepatitis - Corticosteroids in the Treatment of Severe Alcoholic Hepatitis</a></li><li><a href="article192.html">ProCESS - Protocol-Based Care for Early Septic Shock</a></li><li><a href="article193.html">ProMISe - Protocolized Resuscitation in Early Septic Shock (ProMISe)</a></li><h2 style="margin-bottom:0;">R</h2> <hr width="100%", align = "left", size="2"><li><a href="article43.html">RACE II - Lenient vs Strict Rate Control in Patients with Atrial Fibrillation</a></li><li><a href="article129.html">RAFT - Cardiac-Resynchronization Therapy in Heart Failure with QRS Complex</a></li><li><a href="article130.html">RALES - Spironolactone for Severe Heart Failure</a></li><li><a href="article282.html">RAMPART - Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus</a></li><li><a href="article330.html">RAVE - Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis</a></li><li><a href="article158.html">RE-ALIGN - Dabigatran versus Warfarin in Patients with Mechanical Heart Valves</a></li><li><a href="article239.html">RE-COVER - Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism</a></li><li><a href="article93.html">RE-DUAL - Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation</a></li><li><a href="article44.html">RE-LY - Dabigatran versus Warfarin in Patients with Atrial Fibrillation</a></li><li><a href="article243.html">RE-VERSE AD - Idarucizumab for Dabigatran Reversal</a></li><li><a href="article258.html">RECOVERY (Covid-19) - Dexamethasone in Hospitalized Patients with Covid-9</a></li><li><a href="article24.html">RED-HF - Darbepoetin Alfa in Systolic Heart Failure and Anemia</a></li><li><a href="article94.html">REDUCE-IT - Icosapent Ethyl for Elevated Triglyceride Levels</a></li><li><a href="article131.html">REMATCH - Left Ventricular Assist Device as Destination Therapy in End-Stage Heart Failure</a></li><li><a href="article285.html">RESCUEicp - Decompressive Craniectomy in Diffuse Traumatic Brain Injury</a></li><li><a href="article151.html">RESPECT - PFO Closure vs. Medical Therapy in Stroke Prevention</a></li><li><a href="article273.html">RITUXVAS - Rituximab versus Cyclophosphamide in ANCA-Associated Vasculitis</a></li><li><a href="article45.html">ROCKET AF - Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation</a></li><li><a href="article171.html">ROSE - Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome</a></li><li><a href="article196.html">Rivers Trial - Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock</a></li><h2 style="margin-bottom:0;">S</h2> <hr width="100%", align = "left", size="2"><li><a href="article176.html">SAFE - Saline versus Albumin Fluid Evaluation (SAFE) in ICU Patients</a></li><li><a href="article165.html">SALT-ED - Balanced Crystalloids versus Saline in Noncritically Ill Adults</a></li><li><a href="article272.html">SAMMPRIS - Stenting vs. Aggressive Medical Therapy for Intracranial Arterial Stenosis</a></li><li><a href="article18.html">SAVE - Captopril in Patients with Left Ventricular Dysfunction After Myocardial Infarction</a></li><li><a href="article132.html">SCD-HeFT - Implantable Cardioverter-Defibrillator in Patients with Congestive Heart Failure</a></li><li><a href="article197.html">SEPSISPAM - Mean Arterial Pressure Targets in Septic Shock</a></li><li><a href="article19.html">SHOCK - Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock</a></li><li><a href="article177.html">SMART-MED and SMART-SURG - Balanced Crystalloids versus Saline in Critically Ill Adults</a></li><li><a href="article198.html">SOAP II - Dopamine and Norepinephrine in Shock</a></li><li><a href="article294.html">SOCRATES - Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack</a></li><li><a href="article133.html">SOLVD - Enalapril for Chronic Heart Failure with Reduced Ejection Fraction</a></li><li><a href="article240.html">SOME - Screening for Occult Cancer in Unprovoked Venous Thromboembolism</a></li><li><a href="article214.html">SONIC - Infliximab, Azathioprine, or Combination for Crohns Disease</a></li><li><a href="article284.html">SPARCL - Atorvastatin for Stroke Prevention</a></li><li><a href="article180.html">SPICE III - Dexmedetomidine for Sedation in Mechanically Ventilated ICU Patients (SPICE III)</a></li><li><a href="article144.html">SPRINT - Systolic Blood Pressure Intervention Trial (SPRINT)</a></li><li><a href="article295.html">SPS3 Clopidogrel-ASA - Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack</a></li><li><a href="article145.html">STEP - Systolic Blood Pressure Intervention in Elderly Hypertensive Patients</a></li><li><a href="article204.html">STEP 1 - Semaglutide in Adults with Overweight or Obesity</a></li><li><a href="article95.html">STICH - CABG in Patients with Heart Failure and Coronary Artery Disease</a></li><li><a href="article266.html">STOP-IT - Antibiotic Therapy for Intraabdominal Infection after Adequate Source Control</a></li><li><a href="article207.html">STOPAH - Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) Trial</a></li><li><a href="article29.html">SURTAVI - TAVR versus Surgery in Patients with Intermediate-Risk Aortic Stenosis</a></li><li><a href="article254.html">SUSTAIN - Crizanlizumab in Sickle Cell Disease</a></li><li><a href="article311.html">SWOG 8949 - Nephrectomy Plus Interferon Alfa-2b versus Interferon Alfa-2b Alone in Metastatic Renal-Cell Cancer</a></li><li><a href="article96.html">SYNTAX - Comparative Efficacy of PCI with Drug-Eluting Stents vs. CABG in Three-Vessel or Left Main Coronary Artery Disease</a></li><h2 style="margin-bottom:0;">T</h2> <hr width="100%", align = "left", size="2"><li><a href="article97.html">TACTICS-TIMI 18 - Early Invasive vs. Conservative Strategy in Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction</a></li><li><a href="article322.html">TALC - Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy</a></li><li><a href="article20.html">TIMACS - Early Versus Delayed Intervention in Acute Coronary Syndromes</a></li><li><a href="article98.html">TNT - Mortality and Morbidity in Patients with Stable Coronary Heart Disease and LDL Cholesterol Levels</a></li><li><a href="article134.html">TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction (TOPCAT Study)</a></li><li><a href="article255.html">TOPPS - Prophylactic Platelet Transfusions in Hematologic Cancers</a></li><li><a href="article325.html">TORCH - Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease</a></li><li><a href="article172.html">TRICC - Restrictive versus Liberal Transfusion Strategy in Critically Ill Patients</a></li><li><a href="article222.html">TRICS III - Restrictive Red-Cell Transfusion Strategy in Cardiac Surgery</a></li><li><a href="article173.html">TRISS - Transfusion Requirements in Septic Shock (TRISS) Trial</a></li><li><a href="article21.html">TRITON-TIMI 38 - Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes</a></li><li><a href="article248.html">TRIUMPH - Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria</a></li><li><a href="article50.html">TTM - Targeted Temperature Management at 33°C Versus 36°C after Cardiac Arrest</a></li><li><a href="article51.html">TTM2 - Hypothermia vs. Normothermia after Out-of-Hospital Cardiac Arrest</a></li><li><a href="article216.html">Transfusion Strategies for Acute Upper Gastrointestinal Bleeding - Restrictive versus Liberal Transfusion Strategy in Patients with Acute Upper Gastrointestinal Bleeding</a></li><li><a href="article305.html">Twice-daily RT for SCLC - Twice-Daily versus Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated with Cisplatin and Etoposide</a></li><h2 style="margin-bottom:0;">U</h2> <hr width="100%", align = "left", size="2"><li><a href="article326.html">UPLIFT - Tiotropium and Outcomes in Chronic Obstructive Pulmonary Disease</a></li><h2 style="margin-bottom:0;">V</h2> <hr width="100%", align = "left", size="2"><li><a href="article135.html">V-HeFT - Vasodilator Therapy for Chronic Congestive Heart Failure</a></li><li><a href="article136.html">V-HeFT II - Enalapril vs. Hydralazine-Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure</a></li><li><a href="article22.html">VA Cooperative Study - Aspirin in Unstable Angina Trial</a></li><li><a href="article202.html">VA-NEPHRON D - Combination Therapy in Patients with Diabetic Nephropathy</a></li><li><a href="article203.html">VADT - Intensive Glucose Control in Type 2 Diabetes</a></li><li><a href="article217.html">VALENCE - Sofosbuvir–Ribavirin for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options</a></li><li><a href="article23.html">VALIANT - Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both</a></li><li><a href="article161.html">VANISH - Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs</a></li><li><a href="article199.html">VASST - Vasopressin vs Norepinephrine in Septic Shock</a></li><li><a href="article156.html">VEST - Wearable Cardioverter-Defibrillator after Myocardial Infarction</a></li><li><a href="article48.html">VITAL (Vitamin D arm) - Vitamin D, Omega-3 Trial (VITAL)</a></li><li><a href="article153.html">VOYAGER-PAD - Rivaroxaban in Peripheral Artery Disease after Revascularization (VOYAGER PAD Trial)</a></li><li><a href="article137.html">Val-HeFT - Valsartan in Heart Failure Patients Already Treated with ACE Inhibitors</a></li><li><a href="article283.html">Veterans Affairs Status Epilepticus Cooperative Study Group - Treatment of Generalized Convulsive Status Epilepticus</a></li><h2 style="margin-bottom:0;">W</h2> <hr width="100%", align = "left", size="2"><li><a href="article241.html">WARFASA - Aspirin for the Secondary Prevention of Venous Thromboembolism</a></li><li><a href="article296.html">WARSS - Warfarin vs. Aspirin in Patients with Recurrent Ischemic Stroke</a></li><li><a href="article155.html">WASID - Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) Trial</a></li><li><a href="article327.html">WISDOM - Inhaled Glucocorticoids in Triple Therapy for Severe COPD</a></li><li><a href="article99.html">WOSCOPS - Pravastatin in the Primary Prevention of Coronary Events</a></li><h2 style="margin-bottom:0;">Y</h2> <hr width="100%", align = "left", size="2"><li><a href="article178.html">Yang-Tobin Study - Weaning from Mechanical Ventilation: Predictive Indices</a></li>    
<ul>
                                                </div>
                                                </html>
                                                